Global Oscillating Positive Expiratory Pressure (OPEP) Market – Industry Trends and Forecast to 2031

Oscillating Positive Expiratory Pressure (OPEP) Market Analysis and Size

The rise in the prevalence of asthma across the globe acts as one of the major factors driving the growth of the oscillating positive expiratory pressure (OPEP) market. The increase in the volume of healthcare expenditure from the various end-users resulted in high demands for medical devices and other healthcare services, and aggressive marketing strategies such as mergers, takeovers, strategic alliances, and partnerships to move ahead of the competitive curve accelerate the market growth. The use of therapies and devices results in improvements related to the healthcare of individuals while declining the risks associated with the re-occurrence of infection, and innovations and advancements for healthcare services further influence the market.

Data Bridge Market Research analyzes that the global oscillating positive expiratory pressure (OPEP) market which was USD 2,531.49 million in 2023, is likely to reach USD 4,041.84 million by 2031, and is expected to undergo a CAGR of 5.80% during the forecast period. “Facemask OECP devices” dominate the product type segment of the market due to the rising demand for facemasks post-pandemic. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Oscillating Positive Expiratory Pressure (OPEP) Market Scope and Segmentation

Market Definition

Oscillating positive expiratory pressure (OPEP) refers to a therapeutic method that includes breathing into an expiratory resistance device assisting in removal of excess secretion present in the lungs of patients. The method provides better ventilation capabilities of the lungs as it declines the gas trapping. This therapy mode is referred to a non-pharmacological therapy method focusing on elimination of mucus hypersecretion resulting in better mobility.              

Global Oscillating Positive Expiratory Pressure (OPEP) Market Dynamics

Drivers

• Growing Prevalence of Respiratory Diseases

The increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis is a significant driver for the OPEP market. OPEP devices are used as part of respiratory therapy to improve lung function and manage respiratory conditions.

• Technological Advancements in the Market

Ongoing technological advancements in healthcare devices contribute to the growth of the OPEP market. Innovations in OPEP devices, such as the development of portable and user-friendly devices, can enhance patient compliance and drive market expansion.

• Rising Aging Population

The global aging population is growing, leading to an increased incidence of respiratory disorders among the elderly. As age is a risk factor for respiratory issues, the aging demographic contributes to the demand for respiratory care devices, including OPEP device.

• Growing Investment for Healthcare Facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.  

Opportunities

• Increasing Trend Toward Home-Based Healthcare

There is an increasing trend toward home-based healthcare and patient self-management. OPEP devices that are designed for home use and are portable provide an opportunity for market growth. Patients prefer convenient and user-friendly devices that allow them to manage their respiratory conditions at home.

• Telehealth and Digital Health Integration

The integration of OPEP devices with telehealth and digital health platforms presents an opportunity for market expansion. Remote patient monitoring, data collection, and virtual consultations can enhance patient care and treatment outcomes. Manufacturers that invest in technology integration may find a growing market for their products.

Restraints

• Stringent Regulatory Approval Processes

The regulatory approval process for medical devices, including OPEP devices, can be lengthy and stringent. Delays in obtaining regulatory approvals may slow down the introduction of new products to the market, hindering the growth potential of manufacturers.

• Competitive Market Landscape

The OPEP market is competitive, with various companies offering similar devices. Intense competition may lead to pricing pressures and reduced profit margins for manufacturers. In addition, the need for differentiation and innovation to stand out in the market can pose challenges for smaller or less-established companies.

Challenges

• Patient Compliance and Adherence

Ensuring consistent and proper use of OPEP devices by patients can be challenging. Patient education and adherence to prescribed treatment regimens are critical for the effectiveness of OPEP therapy. Overcoming barriers to patient compliance, such as discomfort or lack of understanding, is a challenge for healthcare providers and manufacturers.

• Global Supply Chain Disruptions

The OPEP market, like many other industries, can be vulnerable to supply chain disruptions. Factors such as geopolitical events, natural disasters, or global health crises can impact the manufacturing, distribution, and availability of OPEP devices, posing challenges for companies in maintaining a stable supply chain.

This oscillating positive expiratory pressure (OPEP) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the oscillating positive expiratory pressure (OPEP) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In April 2021, Smiths Medical launched the acapella choice blue vibratory PEP therapy system. Acapella is designed to aid in removing secretions for patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis
• In January 2021, AirPhysio, indicated for use as a Positive Expiratory Pressure (PEP) Device, received approval from the United States Food and Drug Administration

Global Oscillating Positive Expiratory Pressure (OPEP) Market Scope

The oscillating positive expiratory pressure (OPEP) market is segmented on the basis of product type, indication, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Facemask OPEP Devices
• Mouthpiece OPEP Devices
• Bottle OPEP Devices

Indication

• COPD
• Asthma
• Atelectasis
• Bronchitis
• Bronchiectasis
• Cystic Fibrosis
• Others

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies/Online Sales

Global Oscillating Positive Expiratory Pressure (OPEP) Market Regional Analysis/Insights

The oscillating positive expiratory pressure (OPEP) market is analyzed and market size insights and trends are provided by country, product type, indication and distribution channel as referenced above.

The countries covered in the market report are the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Turkey, Lithuania, rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, and rest of Middle East & Africa.

North America is expected to dominate the market due to the quick adoption of advanced technologies within the region. Asia-Pacific is expected to witness significant growth during the forecast period due to the surge in the number of patients in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The oscillating positive expiratory pressure (OPEP) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for oscillating positive expiratory pressure (OPEP) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the oscillating positive expiratory pressure (OPEP) market. The data is available for historic period 2010-2020.

Competitive Landscape and Global Oscillating Positive Expiratory Pressure (OPEP) Market Share Analysis

The oscillating positive expiratory pressure (OPEP) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to oscillating positive expiratory pressure (OPEP) market.

Some of the major players operating in the oscillating positive expiratory pressure (OPEP) market are:

• D-R BURTON HEALTHCARE (U.S.)
• Monaghan Medical Corporation (U.S.)
• solopep (U.S.)
• Smiths Medical, Inc. (U.S.)
• Allergan (Ireland)
• Trudell Medical International (Canada)
• R. Cegla GmbH & Co. KG (Germany)
• PARI (Germany)
• Medica Holdings, LLC (U.K.)
• AirPhysio (U.S.)

SKU-50290